Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

US Department of Justice
Express Scripts
Queensland Health
US Army
Federal Trade Commission

Generated: October 24, 2017

DrugPatentWatch Database Preview

Details for Patent: 5,866,581

« Back to Dashboard

Summary for Patent: 5,866,581

Title: Penciclovir for the treatment of post therapeutic neuralgia
Abstract:A method for the treatment of PHN in mammals, including humans, which method comprises administering an effective amount of a compound of formula (A), or a pharmaceutically acceptable salt thereof. ##STR1##
Inventor(s): Boon; Ronald James (Dorking, GB2), Griffin; David Ronald John (Bishop's Stortford, GB2)
Assignee: SmithKline Beecham p.l.c. (Brentford, GB2)
Application Number:08/624,466
Patent Claim Types:
see list of patent claims

No matches for this query

Foreign Priority and PCT Information for Patent: 5,866,581

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
United Kingdom9320485Oct 05, 1993
United Kingdom9321255Oct 14, 1993
PCT Information
PCT FiledOctober 04, 1994PCT Application Number:PCT/GB94/02156
PCT Publication Date:April 13, 1995PCT Publication Number: WO95/09632

International Patent Family for Patent: 5,866,581

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Canada2173505► Subscribe
Germany69430545► Subscribe
Denmark0804199► Subscribe
European Patent Office0735878► Subscribe
United Kingdom9320485► Subscribe
Spain2176258► Subscribe
European Patent Office0804199► Subscribe
Canada2179282► Subscribe
China1135180► Subscribe
China1082816► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Queensland Health
Argus Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

Google Plus